Trial record 12 of 213 for:    heart surgery OR coronary artery bypass surgery OR heart transplant | Open Studies | NIH, U.S. Fed

Continuous Glucose Monitoring Technology in the Perioperative Period During Cardiac Surgery

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2011 by Yale University.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Medtronic
Information provided by:
Yale University
ClinicalTrials.gov Identifier:
NCT01394588
First received: July 12, 2011
Last updated: July 13, 2011
Last verified: July 2011
  Purpose

This is an observational study of continuous glucose monitoring technology during cardiac surgery. The investigators would like to develop data for descriptive analysis of a comparison of continuous glucose monitoring with a gold standard under the conditions of cardiac surgery.


Condition Intervention
Cardiac Surgery
Device: Use of continuous glucose monitor during surgery. ( Medtronic Minimed Guardian REALTime Continuous Glucose Monitor)

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Prospective Observational Trial of Continuous Glucose Monitoring Technology in the Perioperative Period During Cardiac Surgery

Resource links provided by NLM:


Further study details as provided by Yale University:

Estimated Enrollment: 50
Study Start Date: August 2010
Groups/Cohorts Assigned Interventions
Cardiac Surgery Patients
Competent Adult Patients going for elective cardiac surgery.
Device: Use of continuous glucose monitor during surgery. ( Medtronic Minimed Guardian REALTime Continuous Glucose Monitor)
Use of continuous glucose monitor during surgery.
Other Name: Medtronic Minimed Guardian REALTime Continuous Glucose Monitor

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Competent adults scheduled for elective cardiac surgery.

Criteria

Inclusion Criteria:

  • Competent adults scheduled for elective cardiac surgery.

Exclusion Criteria:

  • Inability to consent, emergency surgery.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01394588

Contacts
Contact: Robert Schonberger, MD 2037852802 robert.schonberger@yale.edu

Locations
United States, Connecticut
Yale New Haven Hospital Recruiting
New Haven, Connecticut, United States, 06510
Sponsors and Collaborators
Yale University
Medtronic
Investigators
Principal Investigator: Robert Schonberger, MD Yale University
  More Information

No publications provided

Responsible Party: Robert Schonberger, Yale University
ClinicalTrials.gov Identifier: NCT01394588     History of Changes
Other Study ID Numbers: 1006006996
Study First Received: July 12, 2011
Last Updated: July 13, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Yale University:
Cardiac Surgery
Perioperative Glucose Control

ClinicalTrials.gov processed this record on April 17, 2014